Expands access to Fresenius Medical Care's globally established portfolio of advanced kidney replacement therapies in the U.S. FDA clearance of multiFiltratePRO ...
HHS kidney plan takes aim at dialysis market concentration, targeting DaVita and Fresenius' 74% market share to improve care and competition.
Fresenius Medical Care Presents New Research And Evidence-Driven Innovations Aimed At Improving Patient Outcomes During ASN Kidney Week 2026 CI Oct. 19 Fresenius Medical Care AG : Deutsche Bank ...
Fresenius Medical Care Presents New Research And Evidence-Driven Innovations Aimed At Improving Patient Outcomes During ASN Kidney Week 2026 CI Oct. 19 Fresenius Medical Care AG : Deutsche Bank ...
DaVita (DVA) and Fresenius Medical Care (FMS), the leading dialysis providers in the U.S., traded lower on Tuesday after Axios reported that the Trump administration is planning to encourage ...
Fresenius Medical Care is presenting U.S. clinical research and technology-focused studies at ASN Kidney Week 2026 in Denver, October 21–25. Findings include real-world delivery ...
Fresenius Medical Care (FME), the world's leading provider of products and services for people with kidney disease, presents new research ...
MedPage Today on MSN
Deaths halt ICU trial of hemodialysis for acute kidney injury
Patients who received initial intermittent hemodialysis faced higher mortality ...
Open a VIP account (an enterprise account with priority handling, 24/7 dedicated customer care, unlimited usage/users, help on formatting, standards, rules, regulations, policy compliance, etc., and ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities ...
Fresenius Medical Care AG (FME.DE, FME) announced that Shervin J. Korangy will become Chief Executive Officer (CEO) and Chair of the Management Board, effective October 12, 2026. He will succeed Helen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results